CALR and acute myeloid leukemia: To further investigate the correlation of clinicopathological characteristics with RO‐BIR2 sensitivity, we treated these cells with RO‐BIR2 and then used CTG assay to determine their viability and calculated their IC50 in 16 primary AML samples.